Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.60
+0.37 (5.94%)
At close: Feb 27, 2026, 4:00 PM EST
6.47
-0.13 (-1.97%)
After-hours: Feb 27, 2026, 6:22 PM EST
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $285.61 million as of February 27, 2026. Its market cap has increased by 1,984.75% in one year.
Market Cap
285.61M
Enterprise Value
333.32M
1-Year Change
1,984.75%
Ranking
Category
Stock Price
$6.60
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $285.61M, an increase of 158.24%. That is a compound annual growth rate of 8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 46.20M | 64.41% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 285.88M |
| X4 Pharmaceuticals | 284.17M |
| Abeona Therapeutics | 281.80M |
| Alector | 279.43M |
| Palisade Bio | 275.66M |
| Enlivex Therapeutics | 272.99M |
| Aardvark Therapeutics | 272.17M |
| C4 Therapeutics | 269.42M |